Humacyte ATEV Study
- Study HIC#:2000036362
- Last Updated:12/15/2025
This study is looking to see how effective an investigational product (ATEV) is in women with end-stage kidney disease needing hemodialysis. The study compares the ATEV with an arteriovenous fistula for use in hemodialysis.
- Age18 years and older
- GenderFemale only
Contact Us
For more information about this study, including how to volunteer, contact:
Sara Niesobecki
- Phone Number: 1-203-737-5037
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Eligibility Criteria
Female patients with end-stage renal disease currently receiving hemodialysis via catheter who are candidates for the creation of an arteriovenous fistula or graft for dialysis access.